BACKGROUND AND PURPOSE: The purpose of this work was to develop an MR imaging-compatible animal model of reversible embolic stroke. We hypothesize that real-time MR imaging of the brain can be performed during stroke thrombolysis and can provide real-time feedback and guidance on the success of thrombolysis. METHODS: Embolic strokes were induced in 5 adult dogs by the use of autologous blood clots, with a sixth dog serving as an experimental control. Serial MR anatomic and physiologic imaging was performed to track the evolution of the stroke. The apparent diffusion coefficient (ADC) and quantitative cerebral blood flow (qCBF) were compared in the normal and stroke regions. During and after the administration of a chemical thrombolytic agent, MR imaging was performed to assess the outcome of the treatment. RESULTS: Strokes were successfully created in 5 animals. No ADC or qCBF changes were observed in the control animal. Both ADC and qCBF values were found to be significantly different in the region affected by the stroke. Restoration of flow was observed in 1 case. CONCLUSION: We have successfully implemented an MR imaging-compatible canine model of reversible embolic stroke.
BACKGROUND AND PURPOSE: The purpose of this work was to develop an MR imaging-compatible animal model of reversible embolic stroke. We hypothesize that real-time MR imaging of the brain can be performed during stroke thrombolysis and can provide real-time feedback and guidance on the success of thrombolysis. METHODS:Embolic strokes were induced in 5 adult dogs by the use of autologous blood clots, with a sixth dog serving as an experimental control. Serial MR anatomic and physiologic imaging was performed to track the evolution of the stroke. The apparent diffusion coefficient (ADC) and quantitative cerebral blood flow (qCBF) were compared in the normal and stroke regions. During and after the administration of a chemical thrombolytic agent, MR imaging was performed to assess the outcome of the treatment. RESULTS:Strokes were successfully created in 5 animals. No ADC or qCBF changes were observed in the control animal. Both ADC and qCBF values were found to be significantly different in the region affected by the stroke. Restoration of flow was observed in 1 case. CONCLUSION: We have successfully implemented an MR imaging-compatible canine model of reversible embolic stroke.
Authors: Jordin D Green; Reed A Omary; J Paul Finn; Richard Tang; Yongzhong Li; James Carr; Debiao Li Journal: J Magn Reson Imaging Date: 2002-07 Impact factor: 4.813
Authors: Timothy J Carroll; Vincenzo Teneggi; Mathieu Jobin; Lisa Squassante; Valerie Treyer; Thomas F Hany; Cyrill Burger; Liqun Wang; Alan Bye; Gustav K Von Schulthess; Alfred Buck Journal: J Cereb Blood Flow Metab Date: 2002-09 Impact factor: 6.200
Authors: I L Katzan; A J Furlan; L E Lloyd; J I Frank; D L Harper; J A Hinchey; J P Hammel; A Qu; C A Sila Journal: JAMA Date: 2000-03-01 Impact factor: 56.272
Authors: Harald H Quick; Michael O Zenge; Hilmar Kuehl; Gernot Kaiser; Stephanie Aker; Sandra Massing; Silke Bosk; Mark E Ladd Journal: Magn Reson Med Date: 2005-02 Impact factor: 4.668
Authors: J Broderick; T Brott; R Kothari; R Miller; J Khoury; A Pancioli; J Gebel; D Mills; L Minneci; R Shukla Journal: Stroke Date: 1998-02 Impact factor: 7.914
Authors: Mohammed Salman Shazeeb; Robert M King; Olivia W Brooks; Ajit S Puri; Nils Henninger; Johannes Boltze; Matthew J Gounis Journal: Transl Stroke Res Date: 2019-09-03 Impact factor: 6.829
Authors: T Bley; C M Strother; K Pulfer; K Royalty; M Zellerhoff; Y Deuerling-Zheng; F Bender; D Consigny; R Yasuda; D Niemann Journal: AJNR Am J Neuroradiol Date: 2010-01-06 Impact factor: 3.825
Authors: Claire R Sharp; Marie-Claude Blais; Corrin J Boyd; Benjamin M Brainard; Daniel L Chan; Armelle de Laforcade; Robert Goggs; Julien Guillaumin; Alex Lynch; Erin Mays; Duana McBride; Tommaso Rosati; Elizabeth A Rozanski Journal: J Vet Emerg Crit Care (San Antonio) Date: 2022-07